An Antibody-Drug Conjugate (ADC) comprises a drug linked to an anitbody. The anitbody binds selectively to cancer cells to deliver the drug into the cell.

今日，迈威生物宣布与深势科技达成战略合作。双方将充分发挥各自在生物药研发和人工智能（AI）大模型领域的优势，共同打造生物药研发大模型平台。而就在不久前，迈威生物宣布与英矽智能达成战略合作，基于双方各自在ADC研发和人工智能（AI）领域的技术优势，以AI赋能ADC创新药研发。

The antibody-drug conjugate (ADC) field is advancing at an unprecedented pace, with groundbreaking innovations and soaring investment. A 33% rise in new drugs, a surge in clinical trials, and ...

Puxitatug samrotecan (P-Sam), an investigational antibody-drug conjugate (ADC) targeting B7-H4-expressing tumors, showed promising efficacy in patients with advanced or metastatic endometrial ...

LAUSANNE, Switzerland, March 25, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today ...